Social Sciences · Education
Gelatin Coated Hybrid\nLipid Nanoparticles for Oral\nDelivery of Amphotericin B
Sanyog Jain (831152), Pankaj U. Valvi (2049277), Nitin K. Swarnakar (2049274), Kaushik Thanki (1497706)
See on the mapAbstract
Amphotericin B (AmB) loaded polymer lipid hybrid nanoparticles\n(AmB-PLNs) comprised of lecithin (anionic lipid) and gelatin (Type\nA, cationic below its isoelectric point 7.0–9.0) were prepared\nby a two-step desolvation method to improve the oral bioavailability\nof AmB. The optimized AmB-PLNs were found to have particle size 253\n± 8 nm, polydispersity index (PDI) 0.274 ± 0.008, and entrapment\nefficiency 50.61 ± 2.20% at 6% w/w of initial theoretical drug\nloading. Scanning electron microscopy (SEM) revealed spherical shaped\nnanoparticles whereas confocal laser scanning electron microscopy\n(CLSM) and fluorescent resonance energy transfer (FRET) analysis confirmed\nthe orientation of the lecithin (located in the core) and gelatin\n(exterior coat) within the system. The developed formulation exhibited\na sustained drug release profile with a release pattern best fitted\nto Higuchi kinetics. Experiments on Caco-2 cell lines revealed a 5.89-fold\nincrease in the intestinal permeability of AmB-PLNs whereas <i>in vivo</i> pharmacokinetic studies exhibited a 4.69-fold increase\nin the oral bioavailability upon incorporation of AmB into PLNs as\ncompared to that of free drug. The developed formulation showed significantly\nlesser hemolytic toxicity as compared to the free drug, Fungizone\n(micellar solution of AmB) and Fungisome (liposomal formulation of\nAmB). Furthermore, blood urea nitrogen (BUN) and plasma creatinine\nlevels, indicative of nephrotoxicity, were also found to be significantly\nlesser for developed PLN formulation as compared to free drug and\nFungizone while comparable to that of Fungisome. The histopathology\nof the kidney tissues further confirmed the absence of any changes\nin the morphology of the renal tubules.